ConductScience.org, home

Paper33859653

Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.

Younas M and 17 others. Front Immunol, 2021. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy. Papers, record 33859653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859653

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.22
iCite
Revised in PubMed
2021-10-21
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Younas MMehwish
2Psomas CChristina
3Reynes CChristelle
4Cezar RRenaud
5Kundura LLucy
6Portalès PPierre
7Merle CCorinne
8Atoui NNadine
9Fernandez CCéline
10Le Moing VVincent
11Barbuat CClaudine
12Sotto AAlbert
13Sabatier RRobert
14Winter AAudrey
15Fabbro PPascale
16Vincent TThierry
17Reynes JJacques
18Corbeau PPierre

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiomarkersMajor topic
HIV InfectionsMajor topic
HIV-1Major topic
Host-Pathogen InteractionsMajor topic
ViremiaMajor topic
Adult
Aged
Antiretroviral Therapy, Highly Active
CD4-Positive T-Lymphocytes
Cross-Sectional Studies
Disease Management
Disease Susceptibility
Duration of Therapy
Humans
Lymphocyte Activation
Middle Aged

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117076584Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.PLoS Biol2006https://conductscience.org/library/papers/17076584PubMed
224728071Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.PLoS One2014https://conductscience.org/library/papers/24728071PubMed
321111238Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.Cell2010https://conductscience.org/library/papers/21111238PubMed
430464243HIV-1 Envelope Glycoproteins Induce the Production of TNF-α and IL-10 in Human Monocytes by Activating Calcium Pathway.Sci Rep2018https://conductscience.org/library/papers/30464243PubMed
524041790Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.J Infect Dis2013https://conductscience.org/library/papers/24041790PubMed
628830393Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.BMC Infect Dis2017https://conductscience.org/library/papers/28830393PubMed
729807541Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study.BMC Med2018https://conductscience.org/library/papers/29807541PubMed
826888911Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.J Antimicrob Chemother2016https://conductscience.org/library/papers/26888911PubMed
923332012Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.HIV Med2013https://conductscience.org/library/papers/23332012PubMed
1028426825Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.PLoS Pathog2017https://conductscience.org/library/papers/28426825PubMed
1129950577Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation.Sci Rep2018https://conductscience.org/library/papers/29950577PubMed
1216199516Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16199516PubMed
1322715361Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.PLoS One2012https://conductscience.org/library/papers/22715361PubMed
1427660234Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.Clin Infect Dis2016https://conductscience.org/library/papers/27660234PubMed
1526452565Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.HIV Med2016https://conductscience.org/library/papers/26452565PubMed
1630821898Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?HIV Med2019https://conductscience.org/library/papers/30821898PubMed
1729940869Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015.BMC Infect Dis2018https://conductscience.org/library/papers/29940869PubMed
1824130489Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.PLoS Pathog2013https://conductscience.org/library/papers/24130489PubMed
1931026289Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015.PLoS One2019https://conductscience.org/library/papers/31026289PubMed
2029932084Day-On, Day-Off emtricitabine, tenofovir disoproxil fumarate and efavirenz single tablet regimen (DODO) as maintenance therapy in HIV-infected patients.Infez Med2018https://conductscience.org/library/papers/29932084PubMed

See all 35 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42656593Genomic landscape of HIV-1 proviruses in ART-treated immunological non-responders.Front Immunol2026https://conductscience.org/library/papers/42656593PubMed
42374467Impact of HIV-1 low-level viremia on virologic and immunologic failure during antiretroviral therapy: a retrospective cohort study from 2005 to 2023 in Qinzhou City, Guangxi, China.AIDS Res Ther2026https://conductscience.org/library/papers/42374467PubMed
40791593No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.Front Immunol2025https://conductscience.org/library/papers/40791593PubMed
40569488A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.Curr HIV/AIDS Rep2025https://conductscience.org/library/papers/40569488PubMed
40568740Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.AIDS2025https://conductscience.org/library/papers/40568740PubMed
40335477BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription.Nat Commun2025https://conductscience.org/library/papers/40335477PubMed
38543714HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch.Viruses2024https://conductscience.org/library/papers/38543714PubMed
38166689Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.BMC Infect Dis2024https://conductscience.org/library/papers/38166689PubMed
37955826Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure.Curr HIV/AIDS Rep2023https://conductscience.org/library/papers/37955826PubMed
37954593Low levels of peripheral blood activated and senescent T cells characterize people with HIV-1-associated neurocognitive disorders.Front Immunol2023https://conductscience.org/library/papers/37954593PubMed
37809059Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults.Front Immunol2023https://conductscience.org/library/papers/37809059PubMed
37632071Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study.Viruses2023https://conductscience.org/library/papers/37632071PubMed
37569647Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging.Int J Mol Sci2023https://conductscience.org/library/papers/37569647PubMed
37108729HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs.Int J Mol Sci2023https://conductscience.org/library/papers/37108729PubMed
36907331Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity.Virol Sin2023https://conductscience.org/library/papers/36907331PubMed
36839593Controversies in the Design of Strategies for the Cure of HIV Infection.Pathogens2023https://conductscience.org/library/papers/36839593PubMed
36679927Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients.Vaccines (Basel)2022https://conductscience.org/library/papers/36679927PubMed
35748553Association of Inflammatory Biomarkers and Cardiovascular Risk Scores in an Italian Cohort of HIV Positive Patient Undergoing Antiretroviral Therapy.Curr HIV Res2022https://conductscience.org/library/papers/35748553PubMed
35208887Two-Drug Regimens for HIV-Current Evidence, Research Gaps and Future Challenges.Microorganisms2022https://conductscience.org/library/papers/35208887PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B3GAT127087PubTator's text mininghttps://conductscience.org/library/genes/27087NCBI Gene
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
KRT88P85348PubTator's text mininghttps://conductscience.org/library/genes/85348NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
PC5091PubTator's text mininghttps://conductscience.org/library/genes/5091NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859653

GET https://conductscience.org/api/papers/v1/33859653/references?page=2